A manufacturer of generic pharmaceuticals focused on ophthalmic, injectable, oral liquid, and topical medications sold primarily in the United States. The company historically supplied hospitals, clinics, and retail pharmacies, with a notable presence in sterile ophthalmic and injectable drug produc...
3 members of Congress have disclosed 16 trades in Akorn, Inc. (AKRX), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 9 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-09-24 | JAMES B. RENACCI | sell | $15K – $50K |
| 2024-09-04 | JAMES B. RENACCI | sell | $1K – $15K |
| 2024-07-02 | JAMES B. RENACCI | sell | $1K – $15K |
| 2024-03-11 | JAMES B. RENACCI | buy | $1K – $15K |
| 2017-10-03 | JAMES B. RENACCI | sell | $1K – $15K |
| 2017-06-01 | JAMES B. RENACCI | buy | $15K – $50K |
| 2016-11-14 | JAMES B. RENACCI | buy | $15K – $50K |
| 2015-12-23 | JAMES B. RENACCI | sell | $15K – $50K |
| 2015-10-27 | JAMES B. RENACCI | sell | $1K – $15K |
| 2015-07-22 | JAMES B. RENACCI | buy | $1K – $15K |
| 2015-05-27 | Thomas MacArthur | sell | $1K – $15K |
| 2015-03-20 | JAMES B. RENACCI | sell | $1K – $15K |
| 2015-03-10 | JAMES B. RENACCI | buy | $1K – $15K |
| 2015-02-13 | Thomas R Tillis | sell | $1K – $15K |
| 2014-10-23 | JAMES B. RENACCI | buy | $1K – $15K |
| 2014-06-25 | JAMES B. RENACCI | buy | $15K – $50K |